FDA actions on menopause treatments
Every approval, label change and safety notice FDA has issued for the menopause treatments we follow, newest first: 18 since Dec 16, 2024 (11 label changes, 7 approvals). Read from FDA's press announcements and its record of approved drugs every day, most recently Nov 19, 2026.
The boxed warning on hormone therapy changes one label at a time; where each stands today is on the boxed warning page. What each treatment costs online is on its own page.
2026
Oct 30, 2026
Label change: FDA approved a labeling supplement for Vivelle
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov)
Oct 30, 2026
Label change: FDA approved a labeling supplement for Estradiol
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov) · Estradiol: estradiol patch prices, estradiol gel or spray prices, estradiol pill prices, vaginal estrogen prices, estrogen and progesterone together prices
Oct 20, 2026
Approval: FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
Today, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week.
FDA, its record (fda.gov) · Estradiol: estradiol patch prices, estradiol gel or spray prices, estradiol pill prices, vaginal estrogen prices, estrogen and progesterone together prices
Oct 19, 2026
Approval: FDA approved a generic estradiol and levonorgestrel from Zydus Pharms
FDA Drugs@FDA, its record (accessdata.fda.gov) · Estradiol: estradiol patch prices, estradiol gel or spray prices, estradiol pill prices, vaginal estrogen prices, estrogen and progesterone together prices
May 11, 2026
Approval: FDA approved a generic estradiol from Encube
FDA Drugs@FDA, its record (accessdata.fda.gov) · Estradiol: estradiol patch prices, estradiol gel or spray prices, estradiol pill prices, vaginal estrogen prices, estrogen and progesterone together prices
Feb 12, 2026
Label change: FDA approved a labeling supplement for Enjuvia
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov)
Feb 12, 2026
Label change: FDA approved a labeling supplement for Bijuva
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov)
Feb 12, 2026
Label change: FDA approved a labeling supplement for Prometrium
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov) · Progesterone: progesterone prices, estrogen and progesterone together prices
Feb 12, 2026
Label change: FDA approved a labeling supplement for Cenestin
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov)
Feb 2, 2026
Approval: FDA approved a generic estradiol from Padagis Us
FDA Drugs@FDA, its record (accessdata.fda.gov) · Estradiol: estradiol patch prices, estradiol gel or spray prices, estradiol pill prices, vaginal estrogen prices, estrogen and progesterone together prices
2025
Dec 8, 2025
Approval: FDA approved a generic estradiol from Teva Pharms USA
FDA Drugs@FDA, its record (accessdata.fda.gov) · Estradiol: estradiol patch prices, estradiol gel or spray prices, estradiol pill prices, vaginal estrogen prices, estrogen and progesterone together prices
Oct 24, 2025
Approval: FDA approved Lynkuet (elinzanetant)
FDA Drugs@FDA, its record (accessdata.fda.gov) · Elinzanetant: Lynkuet (elinzanetant) prices
Oct 15, 2025
Approval: FDA approved a generic conjugated estrogens from Novast Labs
FDA Drugs@FDA, its record (accessdata.fda.gov) · Conjugated estrogens: estradiol pill prices, vaginal estrogen prices, estrogen and progesterone together prices
Apr 22, 2025
Label change: FDA approved a labeling supplement for Premarin
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov) · Conjugated estrogens: estradiol pill prices, vaginal estrogen prices, estrogen and progesterone together prices
Apr 22, 2025
Label change: FDA approved a labeling supplement for Prempro
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov) · Medroxyprogesterone acetate: progesterone prices, estrogen and progesterone together prices
Feb 11, 2025
Label change: FDA approved a labeling supplement for Brisdelle
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov) · Paroxetine (low dose): low-dose paroxetine prices
Feb 7, 2025
Label change: FDA approved a labeling supplement for Osphena
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov)
2024
Dec 16, 2024
Label change: FDA approved a labeling supplement for Veozah
A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.
FDA Drugs@FDA, its record (accessdata.fda.gov) · Fezolinetant: Veozah (fezolinetant) prices
FDA actions as FDA's own records state them. A label change can be any change to a product's prescribing information; an approval of a generic does not mean a pharmacy stocks it yet. Not medical advice.